论文部分内容阅读
目的采用３种病原治疗方法比较慢性乙型肝炎的疗效。方法分成自体ＬＡＫ细胞回输、猪苓多糖和干扰素３个治疗组。于治疗前和治疗后１ａ分别检测血清中的ＨＢｅＡｇ、ＨＢＶＤＮＡ观察疗效。结果ＨＢｅＡｇ、ＨＢＶＤＮＡ的阴转率自体ＬＡＫ细胞治疗组分别为３８．８９％、６８．５１％；干扰素治疗组分别为３６．８４％、３６．３６％；猪苓多糖组分别为１６．６７％、１３．３３％，对照组分别为６．６７％、７．１４％。前两组的阴转率明显高于对照组。结论干扰素和自体ＬＡＫ细胞回输治疗慢性乙型肝炎疗效确切。
Objective To compare the curative effects of chronic hepatitis B with three kinds of pathogens. Methods divided into autologous LAK cell transfusion, Polyporus umbellatus and interferon 3 treatment groups. Serum HBeAg and HBVDNA were measured before treatment and after treatment 1a respectively. Results The negative conversion rates of HBeAg and HBVDNA were 38.89% and 68.51% respectively in the LAK cells treated with IFN-γ and 36.84% and 36.36% in the interferon-treated groups, respectively, and those in the Polyporus polysaccharide group were 16.67 %, 13.33%, respectively, the control group were 6.67%, 7.14%. The negative conversion rate of the first two groups was significantly higher than that of the control group. Conclusion The efficacy of interferon and autologous LAK cell transfusion in the treatment of chronic hepatitis B is exact.